Which healthcare stock can dividend investors safely buy? Let's consider two excellent options: AbbVie (NYSE: ABBV) and Amgen (NASDAQ: AMGN).

Using HACE, the team sequenced only those mutated genes and pinpointed several unique changes associated with resistance to ...

The company is paying China-based biotech LaNova Medicines $588 million for the kind of dual-pronged antibody drug that ...

The collaboration between the two companies reflects ongoing efforts to enhance drug development, the CEO of Immunai said.

In a small subset of those patients, the combination resulted in a strong response with tumor shrinkage and no disease ...

Oct. 15 marked the start of Medicare's annual open enrollment period. Seniors can choose to stay on their current plan or ...

MERCK & Co licenced an experimental cancer antibody from a closely held Chinese company in a deal worth US$588 million ...

Imlygic injections take about 10 minutes and are conducted over several months. In clinical trials, Dr. Gushchin says seven ...

New drugs and therapies have become indispensable for treating an array of cancers. Unfortunately, they can also cause damage to the heart, a side effect that has led to the development of a new ...

Researchers have created a groundbreaking antibody that combines targeting, delivery, and immune activation to treat cancer, ...

Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...

In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...